Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005

Epidemiology and Infection

Volumn 136, Issue 3, 2008, Pages 360-369

  Pebody, Richard G ^a   Hippisley Cox, J ^b   Harcourt, S ^c   Pringle, M ^b   Painter, M ^d   Smith, G ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c West Midlands Training Scheme   (United Kingdom)

^d HPA North West ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COCHLEA PROSTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; HEART DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; PRIMARY MEDICAL CARE; SICKLE CELL ANEMIA; SPLEEN DISEASE; STREPTOCOCCUS INFECTION; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; VACCINATION; WALES;

EID: 39049119816     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008436     Document Type: Article

References (25)

1. Melegaro A, et al. The current burden of pneumococcal disease in England and Wales. Journal of Infection 2006; 52: 37-48.
2. Hawker J, et al. Communicable Disease Control Handbook Oxford: Blackwell, 2001.
3. The Green Book (www.dh.gov.uk/PolicyAndGuidance/ HealthAndSocialCareTopics/GreenBook/fs/en). Accessed 1 December 2005.
4. Singleton JA, Santibanez TA, Wortley PM. Influenza and pneumococcal vaccination of adults aged > or= 65: Racial/ethnic differences. American Journal of Preventive Medicine 2005; 29 412-420.
5. Singleton JA, et al. Influenza, pneumococcal, and tetanus toxioid vaccination of adults - United States, 1993-7. Morbidity and Mortality Weekly Reports. CDC Surveillance Summaries 2000; 49: 39-62.
6. Andrews RM, Lester RA. Improving pneumococcal vaccination coverage among older people in Victoria. Medical Journal of Australia 2000; 173 (Suppl.): S45-47.
7. Noakes K, et al. Pneumococcal polysaccharide vaccine uptake in England, 1989-2003 prior to the introduction of a vaccination programme for older adults. Journal of Public Health (Oxford) 2006; 28: 242-247.
8. McDonald P, et al. Pneumococcal vaccine campaign based in general practice. British Medical Journal 1997; 314: 1094-1098.
9. Kyaw MH, Nguyen-Van-Tam JS, Pearson JCG. Family doctor advice is the main determinant of pneumococcal vaccine uptake. Journal of Epidemiology and Community Health 1999; 53: 589-590.
10. Kyaw MH, et al. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies. Epidemiology and Infection 2002; 128: 445-455.
11. Turner DPJ, Finch G. Pneumococcal vaccine uptake in medical patients discharged from a district hospital. Communicable Disease and Public Health 1999; 2: 291-292.
12. Wahid ST, et al. Audit of influenza and pneumococcal vaccination uptake in diabetic patients attending secondary care in the Northern Region. Diabetic Medicine 2001; 18: 599-603.
13. Hippisley-Cox J, Pringle M. Prevalence, care and outcomes for patients with diet controlled diabetes in general practice: Cross sectional survey. Lancet 2004; 364: 423-425.
14. Hammersley V, et al. A comparison of research General Practices and their patients with other practices - cross sectional survey in Trent. British Journal of General Practice 2002; 52 463-468.
15. Nuorti JP, et al. Cigarette smoking and invasive pneumococcal disease. Active acterial Core Surveillance Team. New England Journal of Medicine 2000; 342: 681-689.
16. Nichol KL, MacDonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. Journal of General Internal Medicine 1996; 11: 673-677.
17. Wright JA, Polack C. Understanding variation in measles-mumps-rubella immunization coverage - a population-based study. European Journal of Public Health 2006; 16: 137-142.
18. Mangtani P, et al. Inequalities in influenza vaccine uptake emong people aged over 74 years in Britain. Preventive Medicine 2005; 41: 545-553.
19. Reading R, Openshaw S, Jarvis S. Are multidimensional social classifications of areas useful in UK health service research? Journal of Epidemiology and Community Health 1994; 48: 192-200.
20. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. American Journal of Public Health 2003; 93: 2074-2078.
21. Findlay PF, et al. Influenza and pneumococcal vaccination: patient perceptions. Postgraduate Medical Journal 2000; 76: 215-217.
22. McDonald P, et al. Pneumococcal vaccine campaign based in general practice. British Medical Journal 1997; 314: 1094-1098.
23. Siriwardena AN, et al. Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care. British Journal of General Practice 2002; 52: 735-740.
24. Jacobson VJ, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. The Cochrane Database of Systematic Reviews 2005; Issue No. 3, Art. No.: CD003941.
25. Stone EG, et al. Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Annals of Internal Medicine 2002; 136: 641-651.